info@novystem.com
NovystemNovystemNovystemNovystem
  • About us
    • Board of Directors
    • Scientific Team
  • Our Science
    • Biotech
    • Medtech
    • Friedreich Ataxia
    • Bedsores​
  • Pipeline
    • Biotech
    • Medtech
    • Nutraceuticals​
  • Products
  • News
  • Carrers
  • Contacts

Friedreich Ataxia

    Home Friedreich Ataxia

    Novystemnanoclusters have shown an exceptional efficacy in preclinical models and thus represent an ideal therapeutic solution to treat FRDA.

    Oxidative stress plays a central role in disease pathogenesis.

    The condition is characterized by:

    Progressive ataxia of the limbs

    Dysarthria and dysphagia

    Oculomotor dysfunction

    Scoliosis

    Cardyomiopathy

    Diabetes

    Loss of vision and of hearing

    Novystem nanoclusters have shown an exceptional efficacy in preclinical models and thus represent an ideal therapeutic solution to treat FRDA

    Copyright 2022 NovyStem - Privacy Policy - Cookie Policy - Powered by
    • About us
      • Board of Directors
      • Scientific Team
    • Our Science
      • Biotech
      • Medtech
      • Friedreich Ataxia
      • Bedsores​
    • Pipeline
      • Biotech
      • Medtech
      • Nutraceuticals​
    • Products
    • News
    • Carrers
    • Contacts
    Novystem